Immunosuppression and the prognosis of patients suffering from myeloproliferative disorders after liver transplantation

By Bahr M.J.   Rosenau J.   Tietge U.J.F.   Caselitz M.   Hofmann M.W.   Klempnauer J.   Boker K.H.W.   Strassburg C.P.   Manns M.P.  

Transplantation Proceedings, Vol. 34, Iss. 5, 2002-08 ,pp. : 1493-1494

Elsevier

Access to resources Recommend Favorite

Clinical, pathological and molecular features of the chronic myeloproliferative disorders: MPD 2005 and beyond

By Michiels Jan Jacques  

Hematology, Vol. 10, Iss. 1, 2005-09 ,pp. : 215-223

Maney Publishing

Access to resources Recommend Favorite

Stem Cell Defects in Philadelphia Chromosome Negative Chronic Myeloproliferative Disorders: A Phenotypic and Molecular Puzzle?

By  

Current Stem Cell Research & Therapy, Vol. 2, Iss. 3, 2007-09 ,pp. : 253-263

Bentham Science Publishers

Access to resources Recommend Favorite

Leukocyte Function in Chronic Myeloproliferative Disorders

By Wolach B.   Gavrieli R.   Manor Y.   Beutler M.E.  

Blood Cells, Molecules, and Diseases, Vol. 24, Iss. 4, 1998-12 ,pp. : 544-551

Academic Press

Access to resources Recommend Favorite

Molecular genetic evaluation of myeloproliferative neoplasms

By  

International Journal Of Laboratory Hematology, Vol. 37, Iss. S1, 2015-05 ,pp. : 61-71

John Wiley & Sons Inc

Access to resources Recommend Favorite